JPRN-UMIN000030084CompletedPhase 1
Practical evaluation of PET studies with [18F]-GE180, [18F]-FDOPA and [18F]-FLT for a future clinical trial of iPSC-based cell therapy in Parkinson's disease - Practical evaluation of PET studies with three tracers for iPSC derived-neural transplantation
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Kyoto University
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •i) Having communication disorder ii) In severe general condition iii) Having severe infection or other severe complications iv) Having severe drug allergy v) Having difficulty in expression of consent vi) Pregnancy or possible pregnancy. During breast feed vii) Judged as inappropriate by doctors for other reasons in case of [18F]-GE180, [18F]-FLT viii) Surgical history on the site of the disease, which causes possible false-positive signal in case of [18F]-FDOPA ix) Difficulty in withdrawal of listed medication for Parkinson's disease due to medical reasons or dissent
Investigators
Similar Trials
Completed
Not Applicable
Early response evaluation with 18F-FDG PET/CT and immunological profiling of circulating immune cells and tumor-draining lymph nodes in non-small cell lung cancer patients treated with immunotherapy.lung cancerNL-OMON48669Antoni van Leeuwenhoek Ziekenhuis50
Completed
Phase 1
Study of a marker of angiogenic response to combination therapy with pazopanib, and weekly paclitaxel in platinum resistant ovarian cancerGynaecological cancer, ovarian cancerMalignant neoplasm of ovaryCancerISRCTN38286161Imperial College London (UK)17
Completed
Not Applicable
A pilot study for effective evaluations of FLT-PET in the effect of stereotactic radiotherapy on non-small-cell lung cancerJPRN-UMIN000016489Foundation of Biomedical Research and Innovation2
Recruiting
Not Applicable
PET/CT as a Diagnostic Test for Polymyalgia RheumaticaPolymyalgia rheumaticaACTRN12623000290695Rheumatology Clinical Trials, Austin Health60
Completed
Phase 1
Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy ParticipantsAlzheimer's DiseaseNCT02640092Genentech, Inc.72